When was Anumana founded?

Anumana was founded in 2021 and raised its 1st funding round 4 years after it was founded.

Where is Anumana located?

Anumana is headquartered in Cambridge, United States.

Who is the current CEO of Anumana?

Murali Aravamudan of Anumana. They have also founded 1 company.

How many employees does Anumana have?

As of Jul 31, 2026, the latest employee count at Anumana is 181.

Is Anumana a funded company?

Anumana is a funded company, having raised a total of $***** in its 1st and only funding round, a Series C round on Apr 24, 2025.

When was the latest funding round of Anumana?

Anumana's latest funding was a $***** Series C round on Apr 24, 2025, with participation from 4 investors. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $5.44B in funding in 2026 to date.

Where does Anumana rank among its competitors?

Anumana ranks 7th amongst 60 active competitors, of which 18 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was HeartIO, which secured $4.25M in Mar, 2026.

Who are the top competitors of Anumana?

Anumana's top competitors include HeartFocus, Powerful Medical and Laza Medical. Among them, HeartIO secured the most recent funding round in March, 2026.

Anumana - 2026 Company Profile, Team, Funding & Competitors

Anumana is a funded company based in Cambridge (United States), founded in 2021 by Venky Soundararajan. It operates as an AI-based ECG detection and cardiology diagnosis solutions. Anumana has raised an undisclosed amount in funding. The company has 60 active competitors, including 18 funded and 2 that have exited. Its top competitors include companies like HeartFocus, Powerful Medical and Laza Medical.

Company Details

AI-based ECG detection and cardiology diagnosis solutions. The company has developed a predictive biomarker detection tool to decode the ECG records and provide clinical decision and diagnosis support for care providers. The artificial neural network delivers ECH algorithms for early diagnosis and intervention.

Website: anumana.ai
Email ID: *****@anumana.net

Key Metrics

Founded Year

2021

Location

Cambridge, United States

Stage

Funding Raised

Latest Funding Round

Series C, Apr 24, 2025, $*****

Investors

Mayo Clinic & 5 more

Ranked

7^th among 60 active competitors

Employee Count

181 as on Jul 31, 2026

Investment & Acquisitions

Neutrace

Similar Companies

OpenEvidence & 2893 more

View Anumana's full profile

Anumana has raised funding over 1 round. Its latest funding round was a Series C round on Apr 24, 2025 for $*****. 4 investors participated in its latest round. Anumana has 6 institutional investors.

Here is the list of recent funding rounds of Anumana:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 24, 2025	8435040	Series C	3382580	5304117	7234390	4022606

Access funding benchmarks and valuations. Sign up today!

View details of Anumana's funding rounds and investors

The founders of Anumana is Venky Soundararajan.

Here are the details of Anumana's key team members:

Venky Soundararajan: Co-Founder of Anumana and founder of 2 other companies, nference and Qrativ.
Contact Info: 1 email address
Murali Aravamudan: Co-Founder & CEO of Anumana.
Contact Info: 1 email address

View details of Anumana's Founder profiles and Board Members

Anumana's employee count trend

Anumana has 181 employees as of Jul 26. Here is Anumana's employee count trend over the years:

Uncover Anumana's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Anumana include HeartFocus, Powerful Medical and Laza Medical. Here is the list of Top 10 competitors of Anumana, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	HeartFocus 2023, Bordeaux (France), Seed	AI-driven app for healthcare professionals to perform cardiac ultrasound exams	$6M	Racine², BNP Paribas Developpement & 4 others	62/100
2nd	Powerful Medical 2019, Bratislava (Slovakia), Series A	Developer of AI-powered platform for interpreting electrocardiograms and detecting heart conditions	$11.4M	Europa, Venture to Future Fund & 7 others	59/100
3rd	Laza Medical 2022, Los Gatos (United States), Series A	AI-powered robotically-assisted imaging solutions for cardiovascular interventions	$36M	The Capital Partnership, Shifamed & 5 others	57/100
4th	Volta Medical 2016, Marseille (France), Series B	AI-based software developer for providing cardiac mapping assistance tools	$74.2M	Gilde Healthcare, Vensana Capital & 2 others	56/100
5th	CorVista 2012, Toronto (Canada), Series C	Provider of an AI-based cardiac health diagnosis tool for healthcare professionals	$162M	G Ventures, MedVenture Partners & 2 others	55/100
6th	VahatiCor 2021, Santa Clara (United States), Series B	Platform offering solutions on addressing coronary microvascular disease	$23M	S3 Ventures, Intuitive Ventures	52/100
7th	Anumana 2021, Cambridge (United States), Funding Raised	AI-based ECG detection and cardiology diagnosis solutions	-	Mayo Clinic, NTTVC & 4 others	49/100
8th	Cardio Intelligence 2019, Minato City (Japan), Series B	AI-based medical devices for diagnosis and treatment of heart diseases	$3.22M	Shizuoka Bank, SMBC Venture Capital & 6 others	47/100
9th	HeartIO 2019, Pittsburgh (United States), Seed	Provider of AI-based platform for the diagnosis of heart abnormalities	$4.45M	Bessel, VU Venture Partners & 3 others	46/100
10th	Sanolla 2016, Nesher (Israel), Funding Raised	Developer of AI-based digital diagnostics systems to detect multiple diseases	-	Kyto Technology & Life Science, Europa & 1 others	46/100